About the Program
The HealthHIV HIV Prevention Certified Provider™ Certification Program is an online, self-paced CME accredited certification program composed of eight modules in HIV prevention detailing the pertinent clinical and practice information that clinicians need to effectively employ HIV prevention interventions.
Upon successful completion of this program, participants earn a certification recognizing their designation as an HIV Prevention Certified Provider (HIVPCP) and receive a listing in the national online directory of HIVPCPs. The curriculum is updated annually and more frequently as needed, based on approval of new biomedical interventions and the release of evidence-based practices.
The Need for an HIVPCP
Modules
FACULTY
Jonathan Appelbaum, MD, FACP, AAHIVS
EDUCATIONAL OBJECTIVES
Upon completion of this activity, participants will be better able to:
- Explain the history and epidemiology of HIV in the United States
- Describe current policies regarding treatment for and prevention of HIV/AIDS
- Identify strategies for HIV prevention and intervention
- Discuss the economics of HIV
- Describe the role of the HIV Prevention certification
FACULTY
Jonathan Appelbaum, MD, FACP, AAHIVS
EDUCATIONAL OBJECTIVES
Upon completion of this activity, participants will be better able to:
- Describe screening for and diagnosis of HIV Infection
- Explain how to identify HIV risk
- Identify appropriate short behavioral interventions
- Describe the importance of leveraging clinic and community partners
FACULTY
Jonathan Appelbaum, MD, FACP, AAHIVS
Alan McCord
EDUCATIONAL OBJECTIVES
Upon completion of this activity, participants will be better able to:
- Explain how to prevent HIV through post-exposure prophylaxis (PEP) and pre-exposure prophylaxis (PrEP)
- Describe the importance of sexually transmitted infection screening and treatment for HIV prevention
- Describe the meaning of U=U and implications for HIV care
FACULTY
Richard Elion, MD
Brian R. Wood, MD
EDUCATIONAL OBJECTIVES
Upon completion of this activity, participants will be better able to:
- Describe the clinical basics of a pre-exposure prophylaxis intervention, including medication, adherence, and effectiveness
- Explain research findings supporting PrEP efficacy
- Discuss the Center for Disease Control and Prevention’s PrEP guidance including risk assessment, testing, PrEP prescription, PrEP coverage, and follow-up
- Describe emerging modalities for PrEP
FACULTY
Christopher Hucks-Ortiz, MPH
EDUCATIONAL OBJECTIVES
Upon completion of this activity, participants will be better able to:
- Describe the integrated continuum of HIV prevention and treatment
- Discuss the role of intersectional stigma (ie. race, sex, gender, orientation, HIV status), discrimination, trauma, and social determinants of health in HIV risk
- Explain cultural humility and the role it plays in providing HIV care and overcoming barriers to care
- Describe trauma-informed care and its importance in HIV treatment and prevention
- Introduce resources to mitigate financial barriers for clients
FACULTY
Omar Martinez, JD, MPH, MS
Michael Kharfen, BA
Alan McCord
EDUCATIONAL OBJECTIVES
Upon completion of this activity, participants will be better able to:
- Demonstrate knowledge and competency of National PrEP guidelines
- Identify the strengths and limitations of objective adherence monitoring
- Name typical challenges that providers may face when implementing PrEP, and strategies for reducing those challenges
- Provide adherence education, monitoring, and support to PrEP candidates and users
FACULTY
Mauda Monger, PhD, MPH
K Rivet Amico, PhD
Tamara Taggart, PhD, MPH
EDUCATIONAL OBJECTIVES
Upon completion of this activity, participants will be better able to:
- Identify populations vulnerable to HIV infection who also experience disparities around PrEP
- Describe how the social determinants of health and barriers to healthcare impact PrEP uptake
- Identify trends in PrEP use and persistence among different populations
- Describe different navigation models that can improve access to PrEP
- Identify strategies that providers can use to support PrEP adherence among vulnerable populations
FACULTY
Rupa Rajesh Patel, MD, MPH, DTM&H
EDUCATIONAL OBJECTIVES
Upon completion of this activity, participants will be better able to:
- Identify the benefits of using TelePrEP for HIV prevention
- List the various components of a TelePrEP program
- Summarize the role of TelePrEP peer navigators
- Identify three (3) commercial or state-run TelePrEP service providers
- Describe possible challenges that TelePrEP service delivery may cause for clients, providers, or organizations
The HIVPCP National Online Directory
Providers who complete all eight modules will receive the HIVPCP Certification and will be added to the national online directory. This directory is available for clients to locate providers who have demonstrated proficiency in HIV prevention. Access the directory at HIVPCPdirectory.org.
Contact
If you have questions about accessing the online platform, contact [email protected] or call 202.507.4732.
Activity Description
The HIVPCP is a CME/CE multi-module educational certification program that will prepare providers to utilize the most individualized and up-to-date methods to prevent HIV infection. Upon completion of the self-paced program, providers will earn a HIVPCP certificate. The HIVPCP certification demonstrates competency in interdisciplinary, multi-level strategies for HIV prevention.
Participants who complete the certification program will have an understanding of the foundation of HIV epidemiology and policy in the United States, the provider’s role in identifying HIV risk and new cases, high impact strategies to prevent HIV through status-neutral-navigation, clinical guidelines to implement PrEP, and a framework of cultural humility that improves clients’ access to and retention in care. Target Audiences
This activity has been designed to meet the educational needs of infectious disease specialists, internists, primary care physicians, nurses, pharmacists, and other clinicians involved in the care of patients at risk of acquiring or transmitting HIV.
- Media: Enduring Material
- Release date: March 21, 2023
- Expiration date: March 20, 2024
- Time to complete each Module: 60 minutes
Accreditation, Credit, and Support
All modules are accredited and participants can earn up to 8.0 contact hours (CME, MOC, NCPD, CPE) for completion of the certification.
In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute, Inc., HealthHIV, and PVI, PeerView Institute for Medical Education. Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This educational activity is supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.
Physician Continuing Medical Education
Medical Learning Institute, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™ per module. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MOC Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points per module in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.
Participation information will be shared through the ACCME’s Program and Activity Reporting System (PARS).
Continuing Nursing Education
Successful completion of this nursing continuing professional development activity will be awarded 1.0 contact hour(s) and 0.75 contact hour(s) in the area of pharmacology per module.
Continuing Pharmacy Education
Medical Learning Institute, Inc. designates this continuing education activity for 1.0 contact hours (0.1 CEUs) per module of the Accreditation Council for Pharmacy Education.
Universal Activity Number:
- Mod 1: JA0007322-9999-21-055-H01-P
- Mod 2: JA0007322-9999-21-056-H01-P
- Mod 3: JA0007322-9999-21-057-H01-P
- Mod 4: JA0007322-9999-21-058-H01-P
- Mod 5: JA0007322-9999-21-059-H01-P
- Mod 7: JA0007322-9999-21-060-H01-P
- Mod 8: JA0007322-9999-21-061-H01-P
Type of Activity: Knowledge
Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from Medical Learning Institute, Inc., the accredited provider, PVI, PeerView Institute for Medical Education, and HealthHIV, our educational partners, do not have any relevant financial relationship(s) to disclose with ineligible companies unless listed below.
Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Method of Participation
There are no fees for participating in or receiving credit for this CE activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
In order to receive credit, learners must participate in the entire CE activity. A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be emailed to you upon completion.
If requesting MOC/CC credit, the post-test and evaluation are required in their entirety as well as our Board Unique ID number, DOB (MM/DD) (required for all Boards except ABA, ABP, and ABS), and a score of 70% or higher is needed to obtain MOC/CC credit (75% is required for ABS).
For nurses, the post-test and evaluation are required in their entirety and a score of 70% or higher is needed to obtain Nursing Continuing Professional Development (NCPD) contact hours.
For pharmacists, upon receipt of the completed activity evaluation, you will receive an email from [email protected] within 2 weeks. MLI will accept your completed evaluation form for up to 30 days and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/.
Access Questions?
Please note that accounts not accessed after December 31, 2020 may have been deactivated. Please contact [email protected] to reactivate your account or with any questions about accessing the HIVPCP modules.
